Trial Profile

A Phase 1, Two-Part Study of Nasal NT-301 Safety, Tolerability, and Pharmacokinetics in Healthy Volunteers: a Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Investigation Followed by an Open-Label, Two-Way, Two-Period, Crossover Evaluation of NT-301 Bioavailability Compared to Subcutaneous Apomorphine

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 23 Feb 2026

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

19 Feb 2026 Status changed from recruiting to completed.
18 Sep 2025 Interim results published in the Nano PharmaSolutions Media Release
11 Jul 2025 The protocol has been amended to change in Number of Arms.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com